2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 43.198 | 22.823 | 0 | 0 | - | - | - | - | - | - |
Total Income - EUR | 44.066 | 23.314 | 0 | 0 | - | - | - | - | - | - |
Total Expenses - EUR | 47.931 | 21.484 | 74 | 0 | - | - | - | - | - | - |
Gross Profit/Loss - EUR | -3.865 | 1.830 | -74 | 0 | - | - | - | - | - | - |
Net Profit/Loss - EUR | -3.865 | 1.830 | -74 | 0 | - | - | - | - | - | - |
Employees | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
Check the financial reports for the company - Synthesis Pharma S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | - | - | - | 2.340 | 2.380 | 2.405 | 3.723 |
Current Assets | 145.884 | 165.470 | 162.791 | 160.036 | - | - | - | - | - | - |
Inventories | 40.744 | 42.779 | 42.342 | 41.626 | - | - | - | - | - | - |
Receivables | 105.133 | 121.702 | 120.450 | 118.412 | - | - | - | - | - | - |
Cash | 7 | 989 | -2 | -2 | - | - | - | - | - | - |
Shareholders Funds | -543.699 | -546.407 | -540.908 | -531.755 | - | - | - | - | - | - |
Social Capital | 134 | 135 | 134 | 131 | - | - | - | - | - | - |
Debts | 728.935 | 750.209 | 741.640 | 729.090 | - | - | - | - | - | - |
Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4646 - 4646" | |||||||||
CAEN Financial Year | 4646 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.